FDA Staff Flags Concerns on Merck's Chronic Cough Drug FDA Staff Flags Concerns on Merck's Chronic Cough Drug
The U.S. health regulator ' s staff on Wednesday flagged concerns that data on Merck ' s chronic cough drug might not be enough to prove the treatment ' s meaningful benefit.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 16, 2023 Category: Consumer Health News Tags: Family Medicine/Primary Care News Source Type: news
Former Merck CEO Ken Frazier on the responsibility of CEOs to uphold principles despite politics
On this week’s episode of Fortune‘s Leadership Next podcast, co-host Alan Murray talks with former Merck CEO Ken Frazier. In a conversation recorded live at a Deloitte Next Generation CEO event in Washington, D.C., Frazier tells Murray why the decisions he made to leave former U.S. President…#alanmurray #merck #kenfrazier #murray #donaldtrump #healthassurance #generalcatalyst #onetencoalition #georgefloyd #esg (Source: Reuters: Health)
Source: Reuters: Health - November 10, 2023 Category: Consumer Health News Source Type: news
Joint research collaboration between Merck, Purdue University, Argonne National Laboratory, and Improved Pharma
Joint research collaboration results in a better understanding of the structure of amorphous dispersions. Groundbreaking article featured as a cover story for Molecular Pharmaceutics WEST LAFAYETTE, Ind., Nov. 9, 2023 /PRNewswire-PRWeb/ -- Amorphous drugs have become a critical component... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - November 9, 2023 Category: Pharmaceuticals Source Type: news
Merck KGaA Sees Earnings, Sales at Lower Half of Outlook Ranges
Germany’s Merck KGaA expects earnings and sales for 2023 to be at the lower half of its outlook ranges, after reporting lower third-quarter revenue across all segments. The life-sciences and chemical group said Thursday that it now expects net sales trending slightly below the mid-point of its…#merckkgaa (Source: Reuters: Health)
Source: Reuters: Health - November 9, 2023 Category: Consumer Health News Source Type: news
Merck KGaA Beats on Earnings Amid Demand for Cancer Drugs
(Source: Reuters: Health)
Source: Reuters: Health - November 9, 2023 Category: Consumer Health News Source Type: news
Merck KGaA says FY profit to fall to lower half of target range
A logo of drugs and chemicals group Merck KGaA is pictured in Darmstadt, Germany January 28, 2016. REUTERS/Ralph Orlowski/File Photo Acquire Licensing Rights FRANKFURT, Nov 9 (Reuters) - Germany's diversified group Merck KGaA (MRCG.DE) flagged that full-year operating earnings would likely be in…#merckkgaa #darmstadt #merck (Source: Reuters: Health)
Source: Reuters: Health - November 9, 2023 Category: Consumer Health News Source Type: news
FDA Approves Merck ’s Keytruda (pembrolizumab) Plus Gemcitabine and Cisplatin as Treatment for Patients With Locally Advanced Unresectable or Metastatic Biliary Tract Cancer
RAHWAY, N.J.--(BUSINESS WIRE) November 1, 2023 -- Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved Keytruda, Merck’s anti-PD-1 therapy, in... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - November 1, 2023 Category: Drugs & Pharmacology Source Type: news
Investor patience tested as pharmaceutical stocks take a tumble
The Health Care Select Sector SPDR Fund NYSEARCA: XLV was down 3.81% in the past month and 8.03% in the past three months. The latest round of pharmaceutical stock earnings isn't helping sector performance. S&P 500 components Bristol Myers Squibb Co. NYSE: BMY, AbbVie Inc. NYSE: ABBV, Merck & Co.,…#xlv #bristolmyerssquibbco #bmy #abbvieinc #merckco #johnsonjohnsonnyse #jnj #pfizerinc #pfe #amgeninc (Source: Reuters: Health)
Source: Reuters: Health - November 1, 2023 Category: Consumer Health News Source Type: news
Federal coverage of COVID drugs is ending
COVID-19 treatments, including Pfizer's Paxlovid, will begin transitioning to the commercial market this week, with costs of the drugs set to increase. Why it matters: The oral antivirals reduce the risk of hospitalization or death from COVID-19 and until now have been free for patients through…#pfizer #merck #medicare #medicaid #indianhealthservice #departmentofdefense #xavierbecerra (Source: Reuters: Health)
Source: Reuters: Health - October 30, 2023 Category: Consumer Health News Source Type: news
COVID-19 treatments to enter the market with a hefty price tag
The COVID-19 treatments millions of Americans have taken for free from the federal government will enter the private market next week with a hefty price tag. Pharmaceutical giant Pfizer is setting the price for a five-day treatment of Paxlovid at $1,390, but Americans can still access the pills at…#pfizer #merck #medicaid #medicare #tommurphy #indianapolis (Source: Reuters: Health)
Source: Reuters: Health - October 27, 2023 Category: Consumer Health News Source Type: news
What the Israel-Hamas conflict means for Germany's economy – DW
Besides energy dependence, the Middle East is a growing market for German firms. Big regional players are also huge investors in Germany, so what would be the impact of an escalation in the Israel-Hamas conflict? As Israel makes its first incursions into Gaza, the world holds its breath in…#middleeast #israel #gaza #hamas #rolflanghammer #kielinstitute #worldeconomy #dw #merck #siemens (Source: Reuters: Health)
Source: Reuters: Health - October 27, 2023 Category: Consumer Health News Source Type: news
Ghana: First Lady Appeals to Merck for Training More Radiologists for Ghana
[Ghanaian Times] The First Lady, Rebecca Akufo-Addo, has made a passionate appeal to Merck Foundation, to help train more radiologists in Ghana to effectively and efficiently take care of the health needs of Ghanaians. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - October 26, 2023 Category: African Health Tags: Ghana Health and Medicine NGOs and Civil Society West Africa Source Type: news
Is Moderna Stock A Buy After Reiterating Its Guide After Pfizer's Cut?
stock collapsed in mid-October after rival Pfizer (PFE) slashed about $9 billion from its full-year outlook due to declining demand for Covid products. But Moderna retained its guide for $6 billion to $8 billion in full-year sales of Covid vaccine, Spikevax. The company noted the outlook,…#pfe #spikevax #nvax #sanofi #gsk #merck #immatics #carsgen #moderna #fda (Source: Reuters: Health)
Source: Reuters: Health - October 26, 2023 Category: Consumer Health News Source Type: news
Amazon, U.S. GDP, ECB rate decision
Investing.com --Amazon takes the lead as the quarterly earnings season continues, with the tech sector remaining in focus. The European Central Bank is expected to halt its rate-hiking cycle, while investors will also focus on the latest quarterly U.S. growth numbers ahead of next week's Federal…#europeancentralbank #federalreserve #metaplatforms #amazon #facebookandinstagram #meta #markzuckerberg #alphabet #merck #southwestairlines (Source: Reuters: Health)
Source: Reuters: Health - October 26, 2023 Category: Consumer Health News Source Type: news
Amazon earnings, Merck reports, Southwest Airlines: 3 things to watch By
Investing.com -- Stocks weakened, led by a sinking Nasdaq after Alphabet (NASDAQ: )'s miss on revenue expectations from its cloud operations. After the wave of enthusiasm for artificial intelligence in the tech sector, earnings reports are showing that some companies are ahead of others. While…#investingcomstocks #alphabet #google #treasury #federalreserve #jeromepowell #merckcompanyinc (Source: Reuters: Health)
Source: Reuters: Health - October 26, 2023 Category: Consumer Health News Source Type: news
